Tundo G, Grasso G, Persico M, Tkachuk O, Bellia F, Bocedi A
Biomolecules. 2023; 13(10).
PMID: 37892174
PMC: 10604886.
DOI: 10.3390/biom13101492.
Barone E, Di Domenico F, Perluigi M, Butterfield D
Free Radic Biol Med. 2021; 176:16-33.
PMID: 34530075
PMC: 8595768.
DOI: 10.1016/j.freeradbiomed.2021.09.006.
Karnati S, Seimetz M, Kleefeldt F, Sonawane A, Madhusudhan T, Bachhuka A
Front Cardiovasc Med. 2021; 8:649512.
PMID: 33912600
PMC: 8072123.
DOI: 10.3389/fcvm.2021.649512.
Akhtar A, Dhaliwal J, Sah S
Psychopharmacology (Berl). 2021; 238(7):1991-2009.
PMID: 33774703
DOI: 10.1007/s00213-021-05826-7.
Gonzalez-Casimiro C, Merino B, Casanueva-Alvarez E, Postigo-Casado T, Camara-Torres P, Fernandez-Diaz C
Biomedicines. 2021; 9(1).
PMID: 33477364
PMC: 7830943.
DOI: 10.3390/biomedicines9010086.
Target Enzymes Considered for the Treatment of Alzheimer's Disease and Parkinson's Disease.
Kim N, Lee H
Biomed Res Int. 2020; 2020:2010728.
PMID: 33224974
PMC: 7669341.
DOI: 10.1155/2020/2010728.
Fucoidan-Rich Substances from Improve Trimethyltin-Induced Cognitive Dysfunction via Down-Regulation of Amyloid β Production/Tau Hyperphosphorylation.
Park S, Kang J, Kim J, Yoo S, Han H, Chung D
Mar Drugs. 2019; 17(10).
PMID: 31627432
PMC: 6836021.
DOI: 10.3390/md17100591.
Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress.
de Dios C, Bartolessis I, Roca-Agujetas V, Barbero-Camps E, Mari M, Morales A
Redox Biol. 2019; 26:101283.
PMID: 31376793
PMC: 6675974.
DOI: 10.1016/j.redox.2019.101283.
Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?.
Kaufman M, Kanayama G, Hudson J, Pope Jr H
Neurosci Biobehav Rev. 2019; 100:180-207.
PMID: 30817935
PMC: 6451684.
DOI: 10.1016/j.neubiorev.2019.02.014.
Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy.
Nalivaeva N, Turner A
Br J Pharmacol. 2019; 176(18):3447-3463.
PMID: 30710367
PMC: 6715594.
DOI: 10.1111/bph.14593.
The antioxidant xanthorrhizol prevents amyloid-β-induced oxidative modification and inactivation of neprilysin.
Lim C, Han J
Biosci Rep. 2018; 38(1).
PMID: 29330223
PMC: 5794500.
DOI: 10.1042/BSR20171611.
Proteomic Characterization of Armillaria mellea Reveals Oxidative Stress Response Mechanisms and Altered Secondary Metabolism Profiles.
Collins C, Hurley R, Almutlaqah N, OKeeffe G, Keane T, Fitzpatrick D
Microorganisms. 2017; 5(3).
PMID: 28926970
PMC: 5620651.
DOI: 10.3390/microorganisms5030060.
Cerebrovascular disease in ageing and Alzheimer's disease.
Love S, Miners J
Acta Neuropathol. 2015; 131(5):645-58.
PMID: 26711459
PMC: 4835514.
DOI: 10.1007/s00401-015-1522-0.
Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.
Tang W
Trends Endocrinol Metab. 2015; 27(1):24-34.
PMID: 26651592
PMC: 4698235.
DOI: 10.1016/j.tem.2015.11.003.
Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress.
Rosales-Corral S, Tan D, Manchester L, Reiter R
Oxid Med Cell Longev. 2015; 2015:985845.
PMID: 25815110
PMC: 4357132.
DOI: 10.1155/2015/985845.
Mercury Reduces the Enzymatic Activity of Neprilysin in Differentiated SH-SY5Y Cells.
Chin-Chan M, Segovia J, Quintanar L, Arcos-Lopez T, Hersh L, Chow K
Toxicol Sci. 2015; 145(1):128-37.
PMID: 25673500
PMC: 4833038.
DOI: 10.1093/toxsci/kfv037.
White matter hypoperfusion and damage in dementia: post-mortem assessment.
Love S, Miners J
Brain Pathol. 2014; 25(1):99-107.
PMID: 25521180
PMC: 8029367.
DOI: 10.1111/bpa.12223.
Metals and cholesterol: two sides of the same coin in Alzheimer's disease pathology.
Wong B, Hung Y, Bush A, Duce J
Front Aging Neurosci. 2014; 6:91.
PMID: 24860500
PMC: 4030154.
DOI: 10.3389/fnagi.2014.00091.
Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer's Disease.
Grimm M, Mett J, Stahlmann C, Haupenthal V, Zimmer V, Hartmann T
Front Aging Neurosci. 2014; 5:98.
PMID: 24391587
PMC: 3870290.
DOI: 10.3389/fnagi.2013.00098.
Proteolytically inactive insulin-degrading enzyme inhibits amyloid formation yielding non-neurotoxic aβ peptide aggregates.
de Tullio M, Castelletto V, Hamley I, Martino Adami P, Morelli L, Castano E
PLoS One. 2013; 8(4):e59113.
PMID: 23593132
PMC: 3623905.
DOI: 10.1371/journal.pone.0059113.